Healthcare
Live Price
Offline$0.000001
+0.00% today
Window Change
-90.00%
Window
Oct 17, 2025 → Mar 19, 2026
Historical coverage is still filling in
This 1Y daily history view is currently sparse. Use it as directional context while we continue backfilling more history.
Coverage: 7 bars · Oct 17, 2025 → Mar 19, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
NMC Health plc (NMMCF) is a Healthcare stock with a market cap of $2.09K and listed on OTC. The stock last traded around $0.00 and down 90.0% across the available one-year price window (Oct 17, 2025 → Mar 19, 2026). Baseline metrics include revenue growth of +28.3%, EPS growth of +31.9%, a dividend yield of 0.0%. What stands out right now is revenue +28.3%, EPS +31.9%, free cash flow +4.8% with operating margin 18.5% and ROIC 10.6%. Valuation is more restrained than many high-expectation growth names at P/E 0.0 and price/sales 0.0. Stock Foundry combines NMMCF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
NMMCF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
NMMCF Max Drawdown
-99.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for NMMCF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$643.9M
-26.9% YoY
FY Net Income
$76.6M
-6.9% YoY
Free Cash Flow
-$25.6M
-703.1% YoY
Revenue Growth
+28.3%
EPS Growth
+31.9%
Gross Margin
40.9%
Net Margin
12.1%
Income statement
USD
| Metric | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|
| Revenue | 2.1B | 1.6B | 1.2B | 881M | 644M |
| Gross Profit | 841M | 635M | 468M | 305M | 209M |
| Operating Income | 380M | 274M | 184M | 111M | 88M |
| EBITDA | 469M | 334M | 239M | 139M | 102M |
| Net Income | 249M | 186M | 133M | 82M | 77M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|
| Cash & Equivalents | 324M | 202M | 480M | 119M | 80M |
| Total Assets | 3.9B | 2.9B | 2.3B | 1.5B | 951M |
| Total Liabilities | 2.5B | 1.8B | 1.4B | 954M | 497M |
| Shareholder Equity | 1.3B | 1.1B | 907M | 488M | 449M |
| Total Debt | 2.0B | 1.4B | 1.0B | 730M | 376M |
| Net Debt | 1.7B | 1.2B | 569M | 612M | 297M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
86M
+1.9% YoY
Capital Expenditures
111M
-39.4% YoY
Free Cash Flow
26M
-703.1% YoY
Key ratios
Gross Margin
40.9%
Operating Margin
18.5%
Net Margin
12.1%
ROE
20.8%
Debt / Equity
1.53x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.